IL1A and Epstein-Barr virus infection: Furthermore, EBV miR-BHRF-1-2-5p downregulates signaling of the potent inflammatory cytokine interleukin-1 (IL-1) by targeting IL-1 receptor 1 (IL1R1), reducing the immune response to EBV infection, enhancing immune evasion [55].